Sentinel node detection in breast cancer using contrast-enhanced sonography with 25% albumin - Initial clinical experience

Journal of Clinical Ultrasound

Volumn 34, Issue 7, 2006, Pages 317-326

  Omoto, Kiyoka ^a   Hozumi, Yasuo ^a   Omoto, Yawara ^a   Taniguchi, Nobuyuki ^a   Itoh, Kouichi ^a   Fujii, Yasutomo ^a   Mizunuma, Hirobumi ^a   Nagai, Hideo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Albumin; Axilla; Breast cancer; Contrast agent; Contrast enhanced ultrasonography; Sentinel lymph node

Indexed keywords

ALBUMIN; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIENCE; FEMALE; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; SENTINEL LYMPH NODE;

ADULT; AGED; ALBUMINS; AXILLA; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED;

EID: 33748063586     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20241     Document Type: Article

References (28)

1. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
2. Imoto S, Hasebe T. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Jpn J Clin Oncol 1999;29:11.
3. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radio-localization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335.
4. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864.
5. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998;82:1704.
6. Mattrey RF, Kono Y, Baker K, et al. Sentinel lymph-node imaging with microbubble ultrasound contrast material. Academic Radiol 2002;9(Suppl 1):231S.
7. Omoto K, Mizunuma H, Ogura S, et al. New method of sentinel node identification with ultrasonography using albumin as contrast agent: a study in pigs. Ultrasound Med Biol 2002;28:1115.
8. Bruneton JN, Caramella E, Hery M, et al. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986;158:325.
9. Yang WT, Ahuja A, Tang A, et al. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996;16:241.
10. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319.
11. Goldberg BB, Merton DA, Liu JB, et al. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004;230:727.
12. Choi SH, Kono Y, Corberi J, et al. Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 2004;183:513.
13. Hauff P, Reinhardt M, Briel A, et al. Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology 2004;231:667.
14. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345.
15. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336.
16. Noguchi M, Tsugawa K, Kawahara F, et al. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients. Breast Cancer 1998;5:381.
17. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423.
18. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546.
19. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818.
20. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645.
21. Cody HS, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast caner: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13.
22. Cox CE, Furman B, Dupont EL, et al. Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: the Moffitt experience. Ann Surg Oncol 2001;11:222S.
23. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001;8:20.
24. Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol 2001;8(9 Suppl):67S.
25. Bass SS, Cox CE, Ku NN, et al. The role of sentinel lymph node biopsy in breast cancer. J Am Coll 1999;189:183.
26. Siegel BM, Mayzel JA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer; an analysis of 259 consecutive patients. Arch Surg 1990;125:1144.
27. Boova RS, Bonanni R, Rosato FE. Patterns of axillary nodal involvement in breast cancer. Ann Surg 1982;196:643.
28. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion: an analysis of 539 cases. Cancer 1987;59:682.